Details for 2017785013
Up to date per 02.04.2026
Actions
Details for 2017785013
Granted/Registered
European Patent
31.07.2019 A
17.12.2025 B1
23.09.2016
US
201662399180 P
14.09.2017
US
201762558557 P
C07K 16/18 20060101AFI20180330BHEP
Owner
Teva Pharmaceuticals International GmbHSchlüsselstrasse 12 8645 Rapperswil-JonaCH
Representative
No representatives present
Inventor
BIGAL, Marcelo4269 Arbor Lane Doylestown Pennsylvania 18902US
AYCARDI, Ernesto1 Deerberry Lane Andover Massachusetts 10810US
Information about Fees